ARCHIVES

ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

List of core grants renewed in FY 2003, full list of center grants.

January 16, 2004

Smoking, Drinking Factors Affect Adherence to Preventive Regimen

September 30, 2011

Obey Explains Cuts In Control, Construction Funds; House Passes HEW Appropriations Bill

July 6, 1979

NCI Appropriations, Authorization Bills Passed By House

September 5, 1980

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013